Could AlphaFold revolutionize chemical therapeutics?

Alexander B Tong¹, Jason D Burch^{2

3}, Daniel McKay^{2

3}, Carlos Bustamante⁴, Michael A Crackower^{2

3}, Hao Wu^{5

6}

Affiliations

¹ Jason L. Choy Laboratory of Single-Molecule Biophysics, Institute for Quantitative Biosciences-QB3, and Chemistry Graduate Group, University of California Berkeley, Berkeley, CA, USA.
² Ventus Therapeutics, Waltham, MA, USA.
³ Ventus Therapeutics, Montreal, Canada.
⁴ Department of Molecular and Cell Biology, Department of Physics, and Department of Chemistry, Howard Hughes Medical Institute, University of California Berkeley, Berkeley, CA, USA.
⁵ Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. wu@crystal.harvard.edu.
⁶ Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA. wu@crystal.harvard.edu.

Alexander B Tong et al. Nat Struct Mol Biol. 2021 Oct.

. 2021 Oct;28(10):771-772.

doi: 10.1038/s41594-021-00670-x.

Alexander B Tong¹, Jason D Burch^{2

3}, Daniel McKay^{2

3}, Carlos Bustamante⁴, Michael A Crackower^{2

3}, Hao Wu^{5

6}

¹ Jason L. Choy Laboratory of Single-Molecule Biophysics, Institute for Quantitative Biosciences-QB3, and Chemistry Graduate Group, University of California Berkeley, Berkeley, CA, USA.
² Ventus Therapeutics, Waltham, MA, USA.
³ Ventus Therapeutics, Montreal, Canada.
⁴ Department of Molecular and Cell Biology, Department of Physics, and Department of Chemistry, Howard Hughes Medical Institute, University of California Berkeley, Berkeley, CA, USA.
⁵ Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. wu@crystal.harvard.edu.
⁶ Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA. wu@crystal.harvard.edu.

No abstract available

References